Department of Pathology Microbiology and Immunology

blood draw

VUMC Diagnostic Laboratories expand, improve services

Vanderbilt University Medical Center’s Diagnostic Laboratories continue to expand in-house services in order to more efficiently diagnose and treat patients. A recent survey indicates clinicians’ overall satisfaction with the efforts.

New staph virulence factor

Jun. 28, 2018—The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections.

Karijolich named 2018 Pew Biomedical Scholar

John Karijolich, PhD, assistant professor of Pathology, Microbiology, and Immunology at Vanderbilt University Medical Center, has been named a Pew Biomedical Scholar by The Pew Charitable Trusts.

HIV virus

A “public” target for HIV

Common sequences of antibodies against HIV may be key to developing a successful vaccine strategy for the virus.

New target to stop Ebola

A new Vanderbilt study suggests it may be possible to develop antibody therapies or a universal vaccine effective against multiple Ebola virus family members.

Alphavirus “Achilles heel”

Targeting the protein that mosquito-borne viruses use to enter cells could be a strategy for preventing infection by multiple emerging viruses.

1 16 17 18 19 20 32